SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 13,098.77 |
| Enterprise Value ($M) | 12,751.07 |
| Book Value ($M) | 5,657.99 |
| Book Value / Share | 29.69 |
| Price / Book | 2.32 |
| NCAV ($M) | 1,901.48 |
| NCAV / Share | 9.98 |
| Price / NCAV | 6.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.06 |
| Return on Equity (ROE) | 0.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.29 |
| Current Ratio | 5.33 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3,232.43 |
| Assets | 6,988.94 |
| Liabilities | 1,330.95 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,853.91 |
| Operating Income | 570.21 |
| Net Income | 426.86 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 572.84 |
| Cash from Investing | 136.49 |
| Cash from Financing | -526.45 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Capital Research Global Investors | |||
| 13G | Viking Global Investors Lp | 5.10 | ||
| 13G/A | Vanguard Group Inc | 10.00 | 5.23 | |
| 13G/A | BlackRock, Inc. | 12.00 | 54.53 | |
| 13G/A | Dodge & Cox | 7.40 | -2.71 | |
| 13G/A | Primecap Management Co/ca/ | 9.78 | 4.74 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 337,804 | 1,920,758 | 17.59 | |
| 655,432 | 3,853,768 | 17.01 | |
| 212,708 | 1,168,343 | 18.21 | |
| 152,963 | 804,202 | 19.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BIIB – Biogen Inc. | BLUE – bluebird bio, Inc. |
| BMEA – Biomea Fusion, Inc. | BPMC – Blueprint Medicines Corporation |
| CABA – Cabaletta Bio, Inc. |
Financial data and stock pages provided by
Fintel.io